Cargando…

Efficacy and Safety of Modified Pranlukast (Prakanon(®)) Compared with Pranlukast (Onon(®)): A Randomized, Open-Label, Crossover Study

INTRODUCTION: Pranlukast is a leukotriene receptor antagonist (LTRA) that is used as an additional controller of mild to moderate asthma. This study compared the efficacy and side effects of two bioequivalent preparations of pranlukast: original pranlukast (Onon(®); Ono Pharmaceutical, Japan) and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seo W., Kim, Hunam, Ryu, Yon J., Lee, Jin H., Shim, Sung S., Kim, Yoo K., Chang, Jung H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951783/ https://www.ncbi.nlm.nih.gov/pubmed/27499820 http://dx.doi.org/10.2174/1874306401610010036

Ejemplares similares

A Case of Pranlukast-Induced Anaphylactic Shock
por: Kim, Sujeong, et al.
Publicado: (2016)

Metabolite Dysregulation by Pranlukast in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022)

Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization
por: Ha, Eun-Sol, et al.
Publicado: (2015)

Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamber
por: Endo, Shuichiro, et al.
Publicado: (2012)

Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection
por: Kubota, Jun, et al.
Publicado: (2022)

Self-microemulsifying drug-delivery system for improved oral bioavailability of pranlukast hemihydrate: preparation and evaluation
por: Baek, Myoung-Ki, et al.
Publicado: (2013)

195 The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma
por: Ogawa, Norifumi, et al.
Publicado: (2012)

Pranlukast reduces asthma exacerbations during autumn especially in 1- to 5-year-old boys
por: Morita, Yoshinori, et al.
Publicado: (2017)

Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells
por: Velázquez-Quesada, Inés, et al.
Publicado: (2020)

Placebo-controlled study with OHIO chamber of prophylactic pranlukast for children with Japanese cedar pollinosis: TOPIC-J III study
por: Hosoya, Kei, et al.
Publicado: (2014)

Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children: a randomized, double-blind, placebo-controlled trial
por: Ebisawa, Motohiro, et al.
Publicado: (2015)

A randomized controlled phase II clinical trial comparing ONO‐4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis
por: Okubo, K., et al.
Publicado: (2017)

Plug in with onOne software: a photographer's guide to vision and creative expression
por: Young, Nicole S
Publicado: (2013)

Hydrolytically Stable and Cytotoxic [ONON](2)Ti(IV)-Type Octahedral Complexes
por: Pedko, Anastasia, et al.
Publicado: (2022)

Plankton community and the relationship with the environment in saline lakes of Onon-Torey plain, Northeastern Mongolia
por: Afonina, Ekaterina Yu., et al.
Publicado: (2018)

pp elastic scattering polarization transfer $K_{onno}$ and depolarization $D_{onon}$ between 1.94 and 2.80 GeV
por: Allgower, C E, et al.
Publicado: (1998)

Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study
por: Jin, Byung Hak, et al.
Publicado: (2018)

Clearing and Labeling Techniques for Large-Scale Biological Tissues
por: Seo, Jinyoung, et al.
Publicado: (2016)

Pharmacokinetic Interactions Between Bazedoxifene and Cholecalciferol: An Open-Label, Randomized, Crossover Study in Healthy Male Volunteers
por: Lee, Moon Hee, et al.
Publicado: (2023)

Erratum to: Clearing and Labeling Techniques for Large-Scale Biological Tissues
por: Seo, Jinyoung, et al.
Publicado: (2019)

First measurement of the $\overline{p}p \rightarrow \overline{n}n$ depolarization parameter D(onon) at 546 MeV/c and 875 MeV/c
por: Ahmidouch, A, et al.
Publicado: (1995)

Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers
por: Kim, Hyungsub, et al.
Publicado: (2018)

Pharmacokinetic interaction between udenafil and dapoxetine: a randomized, open-labeled crossover study in healthy male volunteers
por: Kim, Yo Han, et al.
Publicado: (2015)

The effect of modulated electro-hyperthermia on the pharmacokinetic properties of nefopam in healthy volunteers: A randomised, single-dose, crossover open-label study
por: Lee, Sun Young, et al.
Publicado: (2015)

Open label, randomized, crossover pilot trial of high-resolution, relational, resonance-based, electroencephalic mirroring to relieve insomnia
por: Tegeler, Charles H, et al.
Publicado: (2012)

Pharmacokinetic Drug Interaction Between Amlodipine and Tadalafil: An Open-Label, Randomized, Multiple-Dose Crossover Study in Healthy Male Volunteers
por: Kim, Hyungsub, et al.
Publicado: (2022)

Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial
por: King, Brett, et al.
Publicado: (2022)

Efficacy and Safety of a Drug-Free, Barrier-Forming Nasal Spray for Allergic Rhinitis: Randomized, Open-Label, Crossover Noninferiority Trial
por: Nehrig, Julian, et al.
Publicado: (2023)

Efficacy and Safety of Calcipotriol/Betamethasone Dipropionate Ointment for the Treatment of Trachyonychia: An Open-Label Study
por: Park, Jung-Min, et al.
Publicado: (2015)

A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin® in Patients with Type 1 Gaucher Disease
por: Choi, Jin-Ho, et al.
Publicado: (2015)

Pharmacokinetics comparison of solifenacin tartrate and solifenacin succinate: a randomized, open-label, single-dose, 2-way crossover study in healthy male volunteers
por: Kim, Yu-mi, et al.
Publicado: (2018)

Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2014)

Impact of a soy drink on climacteric symptoms: an open-label, crossover, randomized clinical trial
por: Tranche, Salvador, et al.
Publicado: (2016)

Pharmacokinetics and bioequivalence of sunitinib and Sutent(®) in Chinese healthy subjects: an open-label, randomized, crossover study
por: Wang, Yanli, et al.
Publicado: (2023)

Erratum: A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin® in Patients with Type 1 Gaucher Disease
por: Choi, Jin-Ho, et al.
Publicado: (2015)

Pharmacokinetics of atorvastatin and sustained-release metformin fixed-dose combination tablets: two randomized, open-label, 2-way crossover studies in healthy male subjects under fed conditions
por: Choi, Young-Kyung, et al.
Publicado: (2017)

Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study
por: Kim, Seokuee, et al.
Publicado: (2014)

Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients with Hereditary Tyrosinemia Type 1
por: Guffon, Nathalie, et al.
Publicado: (2017)

Palatability and Swallowability of Pimavanserin When Mixed with Selected Food Vehicles: An Exploratory Open-Label Crossover Study
por: Forman, Mark, et al.
Publicado: (2021)

Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study
por: Ye, Zekang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rud8inv2fdb5hbi265bsb8ohb0